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Abstract
Epsilon toxin (Etx) is one of the major lethal toxins produced by Clostridium perfringens
types B and D, being the causal agent of fatal enterotoxemia in animals, mainly sheep and
goats. Etx is synthesized as a non-active prototoxin form (proEtx) that becomes active upon
proteolytic activation. Etx exhibits a cytotoxic effect through the formation of a pore in the
plasma membrane of selected cell targets where Etx specifically binds due to the presence
of specific receptors. However, the identity and nature of host receptors of Etx remain a mat-
ter of controversy. In the present study, the interactions between Etx and membrane lipids
from the synaptosome-enriched fraction from rat brain (P2 fraction) and MDCK cell plasma
membrane preparations were analyzed. Our findings show that both Etx and proEtx bind to
lipids extracted from lipid rafts from the two different models as assessed by protein-lipid
overlay assay. Lipid rafts are membrane microdomains enriched in cholesterol and sphin-
golipids. Binding of proEtx to sulfatide, phosphatidylserine, phosphatidylinositol (3)-phos-
phate and phosphatidylinositol (5)-phosphate was detected. Removal of the sulphate
groups via sulfatase treatment led to a dramatic decrease in Etx-induced cytotoxicity, but
not in proEtx-GFP binding to MDCK cells or a significant shift in oligomer formation, pointing
to a role of sulfatide in pore formation in rafts but not in toxin binding to the target cell mem-
brane. These results show for the first time the interaction between Etx and membrane lipids
from host tissue and point to a major role for sulfatides in C. perfringens epsilon toxin
pathophysiology.
Introduction
Clostridium perfringens is a gram-positive and spore-forming anaerobe, comprising five toxi-
notypes (A, B, C, D, and E) classified on the basis of the combinatorial production of four tox-
ins of proteinaceous nature [1]. All five types produce alpha toxin, which is a hemolytic,
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necrotizing and lethal phospholipase C, whereas type B produces beta and epsilon toxins, type
C produces beta toxin, type D produces epsilon toxin (Etx), and type E produces iota toxin.
The A and, to a lesser extent, C strains are residents in the human gut [2], with ruminant ani-
mals being the natural hosts of the B and D strains [3]. Etx is one of the most potent bacterial
toxins known [4], causing fatal enterotoxemia in livestock and, hence, heavy economic losses.
The Etx-encoding gene (etx) is carried by large plasmids, some of them sharing homology with
the enterotoxin-encoding plasmids found in type A strains [5]. Over-proliferation of etx-carry-
ing C. perfringens in intestines under certain circumstances produces large amounts of Etx,
which diffuses through all organs and accumulates preferentially in the brain and kidneys [6].
The lethal effect of Etx, characterized by sudden death and, in some cases, acute neurological
signs [7], has mainly been associated with general edema, also leading to a glutamate-mediated
exocytotoxic effect and neuronal death [7–9]. Etx binds to components of synaptosomal frac-
tions [10], myelinic structures [11, 12], glial cells [13], granule neurons and oligodendrocytes
[14] and causes demyelination [12]. After injections into mice, the toxin shows the capacity to
cross the blood–brain barrier (BBB), enter the brain parenchyma [13, 15] and act on neuronal
cells [16]. In addition, Etx also affects the renal system, producing cytotoxicity of epithelial dis-
tal tubule cells [17–19]. In fact, the MDCK cell line of renal origin is the most sensitive cell line
to Etx [20] among the cell lines tested to date, and hence it has been widely used for the study
of the cytotoxic effect of Etx. Effects on humans appear to be extremely rare, with a few
reported cases of Etx production [21, 22] and two case studies which provide evidence of Etx-
producing C. perfringens strains in patients with gas gangrene [23, 24]. Moreover, Etx is also
cytotoxic to cultured human cells, including the human renal adenocarcinoma cell line ACHN
[25], the human renal leiomyoblastoma cell line G-402 [26], and primary cultures of human
renal tubular epithelial cells (HRTEC) [27].
The toxin is produced as a non-toxic precursor molecule (epsilon protoxin, proEtx) that is
activated by proteolytic cleavage of amino and carboxy terminal peptides [28]. proEtx presum-
ably binds to the same surface cell receptors as the full active molecule and can prevent its bind-
ing and further toxicity [11, 13].
The molecular mechanism of Etx cytotoxicity is apparently well characterized, with three
defined steps: i) binding to a specific receptor on the surface of host cells, ii) oligomerization
and formation of a heptameric pre-pore complex, and iii) insertion into the plasma membrane,
producing an active pore [29]. These three steps lead to ionic imbalance across the membrane
and death in host cells [30]. Thus, Etx has been included in the β-pore-forming toxin family
(β-PFT), which is consistent with studies on the three-dimensional structure of the toxin that
show similarities with aerolysin, a pore-forming toxin from Aeromonas hydrophila [31], and
the ability of Etx to form channels in artificial lipid bilayers [32].
The high specificity of Etx towards defined cellular targets (i.e. MDCK cell line) compared
to its relatively low binding to artificial membranes [33, 34] and the sensitivity of Etx binding
to glycanases [10, 35], supports the existence of a glycoprotein as the receptor for Etx [3, 10, 11,
36]. The in vitro binding of Etx to the hepatitis A virus cellular receptor 1 (HAVCR1), together
with its ability to facilitate Etx cytotoxicity, support the role of HAVCR1 as a putative receptor
for Etx [25, 37]. In addition, there is evidence that more than one receptor molecule can be
involved in the recognition and binding of the toxin to different cell targets [38]. Supporting
this view, other proteins have been revealed as important elements for the cytotoxic activity of
Etx. In particular, caveolin-1 and -2 potentiate Etx-induced cytotoxicity by promoting toxin
oligomerization [39] while Myelin and Lymphocyte protein (MAL) is required for ETX cyto-
toxicity [40].
Besides the existence of a putative protein receptor, a suitable lipid environment is critical
for the binding of Etx to a cell surface [35]. In fact, Etx oligomerizes and forms channels in
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artificial lipid membranes [32] although with much less efficiency than in sensitive cell lines
such as MDCK [33]. In addition, Etx binds to elements situated in cholesterol- and sphingoli-
pid-enriched domains from rat synaptosomes and MDCK cells and forms heptameric channels
within the membrane, causing an increase in potassium ion-permeability [41–43]. However, it
is relevant that the removal of cholesterol from mpkCCDc14 cell membrane impairs Etx oligo-
merization and pore formation, but does not block cellular ATP release and cell necrosis, sug-
gesting an Etx cytotoxic mechanism independent of pore formation [44]. Moreover, although
the effects of cholesterol depletion by a cholesterol synthesis inhibitor, lovastatin, and methyl-
β-cyclodextrin treatment on Etx binding and heptamerization have been examined [43], the
effects of other lipid constituents on Etx binding and heptamerization remain uninvestigated.
In the present study, Etx binding to lipids from detergent-resistant domains from two bio-
logical models (P2 fraction from rat brain and MDCK cells) and to pure membrane lipid com-
ponents was investigated. Lipid binding partners of Etx were identified, and the essential role
of sulfatide in the cytotoxic effect of Etx on MDCK cells was defined, although this lipid plays
no role in Etx binding to target cells. Therefore, a direct link between Etx and its action on sul-
fatide-enriched cells, such as oligodendrocytes or Schwann cells, is proposed.
Materials and Methods
Preparation of P2 fraction from rat brain
The crude synaptosomal fractions (P2) were prepared from 4- to 6-week-old Sprague-Dawley
rat brains, as described previously [45], with slight modifications. Animal samples were
obtained according to a procedure approved by the Ethics Committee in Animal and Human
Experimentation of the Universitat Autònoma de Barcelona (ref. 513R) following the European
Communities Council Directives86/609/CEE, 91/628/CEE and 92/65/CE. The whole brain,
without meninges, was homogenized in 40 vol. (w/v) phosphate buffer (pH 7.4) supplemented
with 0.32 M sucrose. Homogenization was performed with 12 strokes (900 rev/min) of a Potter
homogenizer with a Teflon pestle (0.1 ± 0.15 mm clearance). The homogenate was centrifuged
at 1,000 g for 5 min at 4°C. The supernatant was then centrifuged at 12,000 g for 20 min, both
centrifugations in a JA-25.5 rotor. The obtained pellet was enriched in synaptosomes, and also
contained considerable amounts of myelin and mitochondria. The crude synaptosomal pellet
obtained from one brain was gently resuspended in 10 mL of sodium buffer containing 140
mMNaCl, 5 mM KCl, 5 mM NaHCO3, 1 mMMgCl2, 1.2 mMNa2HPO4, 20 mMHepes/
NaOH, and 10 mM glucose, and the pH was adjusted to 7.4.
Cloning, expression and purification of recombinant Etx and proEtx
Etx, proEtx, proEtx-GST and proEtx-GFP were produced as previously described [13, 46].
Briefly, the expression of the recombinant proteins was induced overnight in the presence of
1 mM isopropyl beta-D-thiogalactopyranoside (IPTG) at room temperature (RT), in 250 mL
of LB medium containing 50 μg/mL of ampicillin. Cells were pelleted and resuspended in ice
cold phosphate buffer (PB) 20 mM pH 7.5 with NaCl 250 mM, sonicated and centrifuged at
12,000g for 20 min. The resultant supernatant was incubated with Glutathione Sepharose 4B
beads (GE Healthcare Life Sciences) for 1 h at 4°C. Finally, the recombinant proteins were
eluted by thrombin cleavage in 20 mM PB, pH 7.5 containing 250 mMNaCl and 2.5 mM
CaCl2. When required, proEtx was fully activated by incubation with trypsin-coated agarose
beads for 30 min at RT (Sigma-Aldrich), thus obtaining the active Etx form. Alternatively,
proEtx was labeled with DyLight 488 (Thermo Scientific) following the manufacturer’s instruc-
tions, for confocal microscopy analysis on MDCK cells. Protein concentration was determined
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by the Bradford method [47], using bovine serum albumin (BSA) as the standard. The purity
of the recombinant proteins was checked by SDS-PAGE and Coomassie Blue staining.
Detergent-resistant membrane extraction
Detergent-resistant membranes (DRM) are an experimental model commonly used to study
the so-called ‘membrane rafts’, which are cholesterol- and sphingolipid-rich dynamic mem-
brane microdomains that incorporate specific proteins. DRM were extracted as described pre-
viously [45]. To obtain DRM, the medium was removed and the synaptosomal P2 fraction or
MDCK cells were rinsed with cold PBS and homogenized at 4°C with sodium buffer containing
1% Triton X-100 by end-over-end mixing. Thereafter, the extracts were adjusted to 45%
sucrose, and overlaid with 7 mL of 35% sucrose in sodium buffer and 2 mL of 5% sucrose in
sodium buffer, inside an ultracentrifugation tube. DRM fractions were isolated by ultracentri-
fugation at 35,000 rpm, for 18 h at 4°C, using a SW41 rotor (Beckman Instruments Inc.). The
gradient was harvested in 12 fractions of 1 mL each. The cholesterol levels in each fraction
were enzymatically determined in a Cobas-Mira automatic analyzer using a commercial reac-
tive mixture specific for total cholesterol quantification (BioSystems, Spain) containing 35 mM
PIPES, pH 7.0, 0.5 mM sodium cholate, 28 mM phenol, 0.2 U/mL cholesterol esterase, 0.1 U/
mL cholesterol oxidase, 0.8 U/mL peroxidase, and 0.5 mM 4-aminoantipirine. Protein concen-
tration in the gradient was determined according to the Bradford method [47]. The correct
extraction of DRM was assessed by means of the presence of protein markers determined by
western blot, using Flotillin-1 and Thy-1 as lipid raft markers, whereas Transferrin receptor
was used as a marker of soluble membranes.
Western-blot analysis
Samples of each fraction from the sucrose gradient were analyzed by SDS-PAGE followed by
western blot analysis. The separated proteins were transferred to a Protran nitrocellulose mem-
brane (Schleicher and Schuell; Dassel, Germany) using a Mini TransBlot Cell 3 (Bio-Rad, USA)
at 100 V for 1 h. The blotting buffer used contained 25 mMTris, 200 mM glycine and 10%meth-
anol (v/v). The membrane filters were blocked for 1 h with Tris-buffered saline, supplemented
with 0.1% Tween 20 and 5% (w/v) defatted powdered milk. Then, the membranes were incu-
bated overnight with the indicated antibody diluted in blocking buffer. The antibody against
Transferrin receptor was from Zymed Laboratories Inc. (San Francisco, CA, USA), the antibody
against Flotilin-1 was from Abcam (Cambridge, UK) the antibody against Thy-1 (clone OX-7)
was a gift from G. Schiavo (Cancer Research UK, London), the polyclonal antibodies against
Caveolin-1 was from BD Transduction Laboratories and the antibody against Myelin Basic Pro-
tein was from Sigma-Aldrich. Next, the membrane filters were incubated for 1 h with a secondary
antibody conjugated with horseradish peroxidase diluted in blocking buffer. Several washes with
Tris-buffered saline/0.1% Tween 20 were performed between each step. The western blots were
developed with luminol-based assay and visualized using a GeneGnome HR chemiluminescence
detection system coupled to a CCD camera (Syngene; Cambridge, UK).
Etx oligomerization was monitored in MDCK cells incubated with Etx, basically according
Fennessey et al. [39]. Briefly, MDCK cell monolayers were grown in 24 well plates and incu-
bated for 30 min at 37°C with Etx (10 or 30 nM). After washing with PBS, cells were lysated
with SDS-PAGE sample buffer and analyzed by western blot [48].
Thin Layer Chromatography (TLC)
Lipids from samples of the DRM fractions were extracted according to the Bligh and Dyer
method [49]. During the extraction, acetic acid (0.057 M) was added to the water phase, in
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order to increase the recovery of acidic phospholipids [50]. Briefly, 960 μL of chloroform/meth-
anol (1:2), 400 μL of chloroform and 200 μL of 0.1 M acetic acid were added, in that order, to
200 μL of sample. After shaking the mixture, the tubes were centrifuged (1,000 rpm, 5 min),
and the organic phase was extracted and evaporated using Speed-Vac. When necessary, evapo-
rated samples were resuspended in 25 μL of chloroform/methanol (4:1) and resolved on silica
high-performance TLC plates using chloroform/methanol/water (68:28:4) when sphingolipid
detection was required, or using chloroform/methanol/NH4OH/water (40:48:5:10) in the case
of phosphoinositides (PIs). Standards (sulfatide, sphingomyelin or monophosphorylated PIs,
all from Sigma-Aldrich) were resolved in parallel and staining of lipids was performed using
primuline.
Protein-lipid overlay (PLO)
Lipids from samples of DRM fractions were extracted as in the case of TLC. Then, lipids were
spotted onto a Hybond-C membrane. The membrane was subsequently air-dried, blocked with
1% defatted milk in PBS for 1 h and overlaid with 2.5 μg/mL of recombinant toxin in blocking
buffer overnight. After three washes with PBS supplemented with 0.1% Tween 20, bound toxin
was detected using a polyclonal specific IgG raised in rabbit [17] and subsequent chemilumi-
nescence, as in the case of western blots. To determine the presence of sulfatide in DRM gradi-
ents, a monoclonal antibody against sulfatide was used [51]. In some analyses, commercial
membranes with spotted lipids were also used (Membrane lipid strips and PIP strips from
Echelon Biosciences, USA) or, alternatively, commercial lipids were spotted onto Hybond C
membranes. These lipids were: 1,2-Diacyl-sn-glycero-3-phospho-L-serine, sulfatide and a
phosphoinositide mix (PIs) from bovine brain (all from Sigma). When indicated, signal inten-
sity was determined using the GeneTools software (Syngene; Cambridge, UK).
Confocal microscopy on MDCK cells
MDCK cells (ATCC, CCL-34) were grown on coverslips to confluence in DMEM-F12 medium
supplemented with L-Glutamine and antibiotics. Cells were washed three times with PBS, and
fixed with 4% paraformaldehyde (PFA) for 12 min at RT. After washing with PBS, cells were
treated for 1 h at 37°C with up to 1 U/mL of sulfatase from Aerobacter aerogenes (Sigma-
Aldrich) or 10 μg/ml of arylsulfatase A (ARSA, Life Technologies) when indicated, and subse-
quently blocked by adding PBS containing 20% normal goat serum (NGS) for 1 h at RT and
incubated either with 300 nM of proEtx-GFP or DyLight 488 conjugated-proEtx in PBS con-
taining 1% normal goat serum for 1 h at RT. After three washes with PBS, the samples were
stained with TO-PRO-3 (1:1000 dilution, Molecular Probes, Invitrogen) for 7 min, washed
again and mounted with an aqueous mounting medium (Fluoromount, SIGMA). Slides were
examined in a spectral confocal microscope (Leica TCS-SL; CCiTUB, Biology Unit of Bellvitge
Campus).
Measurement of cell viability
The cytotoxic effect of Etx on MDCK cells was measured using the MTS (3-(4,5-dimethylthia-
zol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) -based assay (Pro-
mega, Madison, USA). MDCK cells were grown in 96-well plates to confluence in DMEM F12
medium supplemented with L-Glutamine and antibiotics. Cells were incubated with medium
containing sulfatase from Aerobacter aerogenes, at 0.1 or 0.2 U of enzyme per well (1–2 U/mL).
After 90 min, Etx was added at 2 or 5 nM final concentration. After 30 min of incubation at
37°C, 20 μl of MTS assay was added to each well, incubated for 1 h at 37°C and the absorbance
measured with an ELISA plate reader at 490 nM. Controls were obtained by omitting Etx in
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each condition (100% of cell viability) or by adding 100 μL of medium containing 0.1% Triton
X-100 (100% of cell lethality).
Results
Etx and proEtx bind to lipids from DRM extracted with Triton X-100
The specific binding and pore formation of Etx to DRM from synaptosomes and MDCK cells
has been described previously, however the nature of the molecules necessary for binding has
remained elusive [43]. Thus, in the present paper, an analysis of Etx and proEtx binding to lip-
ids extracted from DRM isolated using Triton X-100 was conducted to better define and char-
acterize the molecular nature and elements involved in Etx binding to biological targets. Since
the synaptosome-enriched P2 fraction has already been used in the study of Etx binding to the
nervous system [11], we extracted DRM from the P2 fraction from rat brain (Fig 1). The frac-
tions corresponding to DRM showed relatively low levels of protein (Fig 1A) and high levels of
cholesterol (Fig 1B), although small amounts of cholesterol were also found in fractions 11 and
12. The presence and levels of marker proteins were used to corroborate the isolation of DRM
(Fig 1C). Caveolin-1, another protein highly present in DRM involved in Etx oligomerization
[39], was also detected. Additionally, western blot analysis of Myelin Basic Protein (MBP) cor-
roborates the presence of myelin in the synaptosomal samples, although in small amounts in
DRM fractions (Fig 1C). Thereafter, lipids were extracted from every fraction, as stated in the
Materials and Methods section, spotted onto a nitrocellulose membrane and incubated with
Etx or proEtx. The bound toxin was detected using a PLO assay, which showed that both Etx
and proEtx appear almost exclusively in lipids from the DRM fraction (Fig 1D).
The same kind of experiment was performed in MDCK cells, a cell line highly sensitive to
Etx and extensively used in the study of Etx activity. The results also show that Etx binds exclu-
sively to lipids present in the DRM fraction fromMDCK cells (Fig 2). These results demon-
strate that membrane lipids or lipids present in the DRM can act as binding partners of the
toxin.
proEtx binds to phosphatidylserine, mono-phosphoinositides and
sulfatide
In order to identify the lipids that bind to proEtx, membrane strips spotted with 100 pmols of
pure isolated lipids were used in PLO assays with the toxin (Fig 3). The use of PLO assays with
membrane lipids showed binding of proEtx to PS and to sulfatide but not to any of the other
lipids tested (Fig 3A). The use of membranes with PIs, among others, showed binding of
proEtx to phosphatidylinositol-3-monophosphate (PI(3)P), to phosphatidylinositol-5-mono-
phosphate (PI(5)P) and to PS (Fig 3B) only. It is noteworthy that when GST-tagged proEtx was
used in the same protocol as in Fig 3B, PI(3)P and PI(5)P were also recognized, but not PS
(Fig 3C). In order to corroborate the results shown in Fig 3A and 3B, PLO assays were per-
formed with increasing concentrations of pure sulfatides, pure PS or of a phosphoinositide mix
from bovine brain. In every case, the signal due to proEtx binding increased according to the
quantity of lipid (Fig 3D). PLO assays with increasing quantities of sphingomyelin were used
as a negative control (Fig 3E).
Presence of mono-phosphoinositides and sulfatide in DRM correlate
with their binding to Etx
Lipids from sucrose gradients from DRM extractions were extracted and separated by TLC,
together with standards, in order to study the distribution of some Etx-binding lipids (Fig 4).
Clostridium Perfringens Epsilon Toxin Binding to Membrane Lipids
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Sulfatides appeared as a double band and mostly in the DRM fractions. Individual mono-phos-
phoinositides cannot be separated and identified with TLC, but it was clear that these lipids
appeared in two pools, in DRM as well as in the soluble fraction. Sphingomyelin appeared
exclusively in DRM fractions (Fig 4A). In the case of sulfatide, its presence in DRM fractions
was also analyzed using a monoclonal antibody against sulfatide [51]. The results corroborated
the distribution observed in Fig 4A, with sulfatide appearing mostly in DRM fractions (Fig 4B).
These results strongly supported the previous results, since the lipid partners of Etx were found
in DRM fractions.
Sulfate group from sulfatides is essential for proEtx binding to lipids from
DRM but not for Etx binding to MDCK cells
Sulfatase from Aerobacter aerogenes and Arylsufatase A (ARSA) are enzymes that specifically
cleave the sulfate group present in the sulfatide head of sulfatide. Thus, in order to corroborate
results previously shown and to check the role of the sulfate group in proEtx interaction with
cellular membranes, aliquots of DRM and of soluble fractions from synaptosomes (fractions 3
and 12 from gradients shown in Fig 1, respectively) were left untreated or treated with ARSA.
Fig 1. Etx and proEtx bind to lipids extracted from Triton X-100-DRM (lipid rafts) from rat brain. P2 fraction from brain cortex was treated with 1% Triton
X-100 at 4°C, and detergent-resistant membranes (DRM) were isolated by ultracentrifugation in sucrose gradients. Twelve fractions were harvested after
each gradient, and protein (A) and cholesterol (B) contents were determined, showing that the bulk of cholesterol is found in fractions two and three. Each
histogram is the average ± SD from three independent experiments. (C) MBP, caveolin 1 and “lipid raft”marker proteins (Transferrin receptor, TfR, for soluble
membranes; Flotillin-1 and Thy-1 for rafts) were detected by western blot. (D) Lipids, extracted under the Blight and Dyer method, were spotted onto a
Hybond-C membrane and overlaid with 2.5 μg/mL of recombinant toxin (PLO assay). Bound toxin was detected with a specific polyclonal antibody and
subsequent chemiluminescence. Results shown are representative of three independent experiments.
doi:10.1371/journal.pone.0140321.g001
Clostridium Perfringens Epsilon Toxin Binding to Membrane Lipids
PLOS ONE | DOI:10.1371/journal.pone.0140321 October 9, 2015 7 / 18
Subsequently, lipids were extracted using the Blight and Dyer method, and then a PLO assay
was performed, using proEtx. The results showed that the removal of the sulfate group from
sulfatide strongly impaired proEtx binding to DRM lipids from synaptosomes. Slight binding
of proEtx was also observed in the SF fraction, which also decreased under sulfatase pretreat-
ment (Fig 5A and 5B). In order to corroborate these results, binding of proEtx to galactosylcer-
amide (GC), a product of sulfatase enzymatic action on sulfatide, was assayed by means of PLO
Fig 2. Etx binds to lipids extracted from Triton X-100-DRM (lipid rafts) fromMDCK cells. Cells were
treated with 1% Triton X-100 at 4°C, and detergent-resistant membranes (DRM) were isolated by
ultracentrifugation in sucrose gradients. Twelve fractions were harvested after each gradient, and protein (A)
and cholesterol (B) contents were determined, showing that the bulk of cholesterol is found in fractions three
and four. (C) Marker proteins (Transferrin receptor, TfR, for soluble membranes; Flotillin-1 for rafts) were
detected by western blot to prove DRM extraction without contamination from soluble membranes. (D) Lipids,
extracted under the Blight and Dyer method, were spotted onto a Hybond-C membrane and overlaid with
2.5 μg/mL of recombinant toxin (PLO assay). Bound toxin was detected with a specific IgG and subsequent
chemiluminescence.
doi:10.1371/journal.pone.0140321.g002
Fig 3. proEtx binds to PS, monophosphorylated PIs and sulfatide. (A) and (B) 2.5 μg/mL of proEtx were
overlaid on commercial membranes containing 100 pmols of lipid and detected as in Fig 1. The lipids used
were: Triglyceride (TAG), Phosphatidylinositol (PI), PI (4)-phosphate (PI(4)P), PI (4,5)-bisphosphate, (PI(4,5)
P2), PI (3,4,5)-trisphosphate (PI(3,4,5)P3), Phosphatidylserine (PS), Phosphatidylethanolamine (PE),
Phosphatidic acid (PA), Diacylglycerol (DAG), Cholesterol (Chol), Phosphatidylcholine (PC), Sphingomyelin
(SM), Phosphatidylglycerol (PG), 3-sulfogalactosylceramide (Sulfatide), Cardiolipin (CL), Lysophosphatidic
acid (LPA), Lysophosphocholine (LPC), and Sphingosine 1-Phosphate (S1P). (C) PLO assays with the same
strips as in B were performed with 2.5 μg/mL of proEtx-GST. (D) and (E) Increasing amounts of sulfatide
(Sulf), phosphatidylserine (PS), phosphoinositide mixture from bovine brain (PIs) and SMwere used to
corroborate the presence or absence of proEtx binding. PIs (4 μL) were used as a positive control. Results
shown are representative of three independent experiments.
doi:10.1371/journal.pone.0140321.g003
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assay. The results show the absence of binding of proEtx to GC, but a clear binding to sulfatide
(Fig 5C). Then, MDCK cultures were treated with sulfatase from A. aerogenes, prior to incuba-
tion with proEtx-GFP. The results showed that the removal of sulfate groups does not signifi-
cantly abolish proEtx-GFP binding to MDCK cells (Fig 6), indicating that, although proEtx
binding to sulfatide can occur in some steps of the toxin–cell interaction, this event is not asso-
ciated with the primary binding.
Sulfate removal impairs cytotoxic activity of Etx on MDCK cells
To define the importance of sulfate groups on the cytotoxic activity of Etx, MDCK cells were
incubated with sulfatase from Aerobacter aerogenes (100 mU and 200 mU per well of a 96-well
plate) before the addition of Etx (2 or 5 nM). The removal of sulfate groups significantly
reduced the cytotoxic effect of Etx on MDCK cells (Fig 7), as assessed by MTS assays. This
effect was dependent on the concentration of sulfatase and Etx used (Fig 7A). To check if sulfa-
tase pretreatment of MDCK cells would affect the formation of toxin oligomers, MDCK cells
were incubated with sulfatase (2 U/ml) for 60 min before Etx addition for further 30 min and
the presence of Etx oligomers analyzed by western blot. Although a slight decrease in oligomer
formation was apparent after sulfatase treatment (especially in the 10 nM Etx concentration),
no significant quantitative differences in Etx oligomeriztion were observed under these experi-
mental conditions compared to the control (no sulfatase treatment) situation (Fig 7B).
Fig 4. Binding of Etx correlates with the presence of sulfatide andmono-P IPs in DRM. (A) After DRM
extraction with ultracentrifugation, the fractions from the gradient were pooled as indicated (1/2, 3/4, etc.), and
lipids from the pooled fractions were extracted and resolved with thin layer chromatography, as described in
the Materials and Methods section. Standards are shown on the left (Std). SM, sphingomyelin; Mono-P IP,
monophosphorylated PI. (B) Lipids, extracted under the Blight and Dyer method, were spotted onto a
Hybond-C membrane and overlaid with an anti-sulfatide IgG. The presence of sulfatide in DRM fractions was
corroborated and correlates with the binding of Etx to lipids from DRM. Lipids were extracted and processed
as in Fig 1D.
doi:10.1371/journal.pone.0140321.g004
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Discussion
Etx is one of the most lethal bacterial toxins, being slightly less lethal than botulinum and teta-
nus toxin, and produces a rapid cytotoxic effect. Few cell types are susceptible to Etx cytotoxic-
ity, suggesting the presence of a receptor for Etx that is restricted to these cells. Regarding the
Etx cellular targets in the nervous system, the binding of Etx-GFP to myelin structures, but not
Fig 5. Removal of sulfate group impairs proEtx binding to DRM lipids from synaptosomes. (A) Aliquots
from a DRM fraction (#3) and a soluble fraction (#12, SF) from synaptosomal preparations (see Fig 1) were
treated with 10 U/mL ARSA, lipids were subsequently extracted and spotted onto a Hybond-c membrane.
Binding of proEtx to the processed lipids was then assessed with PLO assay. A representative result is
shown. (B) Quantification of the results shown in (A). The signal intensity from untreated DRM samples is
taken as 100%. Mean ± SD from three experiments is shown. (C) Binding of proEtx to increasing amounts of
galactosylceramide (GC), together with 100 pmols of sulfatide as positive control, was analyzed with the PLO
assay. The results show the absence of binding of Etx to GC.
doi:10.1371/journal.pone.0140321.g005
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to nerve terminals, from mouse brain has been shown, with identical results for both the non-
active prototoxin and the active toxin forms of Etx [11]. Binding to granule cells and to oligo-
dendrocytes from mouse brain has also been shown [14]. The binding of both Etx and proEtx
to detergent-insoluble microdomains (DRM, rafts) was described more than ten years ago in
MDCK cells and in rat synaptosomes [43]. The results suggested that the toxin is concentrated
by binding to an unidentified receptor located preferentially in DRMs and is then induced to
form heptameric pores within the rafts [43]. In a later study, the presence of Etx oligomers
in MDCK rafts was corroborated, also demonstrating that these Etx-containing rafts are
endocytosed and play a crucial role in the Etx-induced vacuolation process [52]. The authors
suggested that the primary receptor of monomeric Etx is localized in non-raft regions of cyto-
plasmic membranes of MDCK cells [52], and that receptors linked with Etx gather in lipid
rafts, where Etx forms oligomers. Etx oligomerization is dramatically reduced in cells devoid of
caveolins, a group of cholesterol-binding proteins which are enriched in lipid rafts, although
the binding of Etx was only slightly perturbed [39], suggesting the presence in the cell mem-
brane of distinct partners of Etx in the binding and oligomerization steps. The results presented
here show the virtually exclusive binding of Etx to lipids contained in rafts, with very low bind-
ing to non-rafts containing lipids. It is noteworthy that our results on lipid binding were
obtained using purified lipids in the absence of membrane structures that could induce toxin
oligomerization. The different systems of study might account for variations in the results
regarding binding to raft and non-raft domains. One additional possibility would be that rafts
containing lipids are directly involved in Etx oligomerization and that the binding of these
lipids to Etx would be a subsequent and required step for oligomerization. In any case, we
found that both proEtx and Etx bind to the lipid fraction present in DRMmembranes from
Fig 6. Sulfate group from sulfatides is not essential for proEtx-GFP binding to MDCK cells.Cells were fixed and subsequently treated with 0.25 U
sulfatase (1U/mL) for 30 min (at 37°C) or left untreated (Control). Next, both cultures were incubated with 300 nM proEtx-GFP for 1 h at 37°C, and visualized
under confocal microscopy. Confocal microscopy images of MDCK cells show the binding of GFP-proEtx to the plasmamembrane (green), as well as the
nuclei (TOPRO-3 in blue), in the absence or the presence of 0.25 U sulfatase from Aerobacter aerogenes pretreatment.
doi:10.1371/journal.pone.0140321.g006
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synaptosomal preparations (Fig 1D), suggesting a similar mechanism both in the MDCK and
in synaptosomal systems.
One of the Etx-binding lipids identified here is PS, which is mainly found in the inner face
of the plasma membrane. However, relatively little is known about binding of proteins from
pathogens to PS. Helicobacter pylori can cause oncogenic conversion of gastric epithelial cells
thanks to the interaction of CagA, a basic protein, with PS in the host cell membrane through a
cluster of consecutive lysine and arginine residues, all of which are situated in one domain of
the protein [53, 54]. Another case involves the protein EspB fromMycobacterium tuberculosis,
which can enhance its virulence thanks to its binding to PS [55].
Fig 7. Sulfatase pretreatment of MDCK cells significantly prevents the cytotoxic effect of Etx but does
not affect toxin oligomerization. (A) MDCK cells were preincubated in the absence or the presence (0.1 or
0.2 U) of sulfatase from Aerobacter aerogenes for 90 minutes at 37°C. Etx was then added at a final
concentration of 2 or 5 nM. After 30 minutes at 37°C, MTS assay was used to determine cell viability. Results
represent mean ± SEM of cell survival compared to controls (0 U), from three experiments. ***p < 0.001 for 5
nM Etx and ###p < 0.001 for 2 nM Etx, when compared with cells without sulfatase treatment, using one-way
ANOVA, followed by the Bonferroni’s post-hoc test. (B) MDCK cells preincubated in absence or presence of
2U/ml of sulfatase were incubated at 37°C with 10 or 30 nM Etx for 30 min. After washing, cells were lysated
and the presence of Etx monomers and oligomers analyzed by western blot. The figure shows a
representative western blot of three independent experiments.
doi:10.1371/journal.pone.0140321.g007
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Monophosphorylated inositides are also located in the intracellular leaflet of the plasma
membrane. Several intracellular pathogenic bacteria from different species, such as Listeria,
Salmonella,Mycobacterium and Legionella spp., exploit the phosphoinositide metabolism to
infect host cells and to use their signaling, establishing a replicative niche [56, 57]. Legionella
pneumophila releases a series of proteins that bind to monophosphorylated PIs, such as LidA
and LpnE, which bind to host PI(4)P and PI(3)P, interfering with host vesicle trafficking and
signaling [58]. Since a series of proteins that bind to PI(3)P, and other PIs, are involved in traf-
ficking of early endosomes, multivesicular bodies and phagosomes [59], some kind of role of
the interaction between Etx and monophosphorylated PIs in the vacuolation process described
during Etx intoxication can be hypothesized [52]. In any case, the interaction of Etx with
monophosphorylated PIs would take place after pore formation, during its internalization
process.
Among the lipids herein identified as Etx binding partners, sulfatide is a candidate for medi-
ating the vulnerability of specific host cells to Etx, since sulfatide is abundant in organs targeted
by Etx, i.e., kidneys, gastrointestinal tract and the nervous system [60]. In the nervous system,
sulfatide accounts for 4% of the total myelin lipids, most of the sulfatide being present in the
plasma membrane of oligodendrocytes and Schwann cells, and the myelinating cells of the cen-
tral and the peripheral nervous systems [61]. The role of sulfatide in the nervous system is not
clear, but abnormal levels of synthesis can potentially affect functional properties of membrane
proteins, such as transporters, receptors and ion channels, causing neurological symptoms
[62]. In myelin structures, sulfatide is essential for paranodal junction formation and for the
maintenance of ion channels on myelinated axons [63, 64]. In fact, sulfatide also binds to MAL
[65], a protein required for Etx cytotoxic effect on target cells [40]. The binding to sulfatide
herein described is consistent with previous work on Etx binding to renal membranes, in
which the involvement of O-glycoconjugates, but not of N-glycans, was demonstrated, since β-
elimination of O-glycans with alkaline conditions dramatically abrogated proEtx-GFP binding
[35]. In fact, sulfatide also binds to many bacteria and to some bacterial proteins [60], as is the
case of STb, a heat-stable enterotoxin from Eschericiha coli strains [66]. The action of STb
results in calcium ion entry in the host cell by means of the opening of a receptor-dependent
ligand-gated Ca2+ channel [67]. Similarly to STb, Etx induces increased [Ca2+]i in both renal
cell lines and cultured cerebellar granule cells [14]. These Etx-induced [Ca2+]i oscillations are
due to the stimulation of mGluR1 metabotropic glutamate receptors, as recently reported in
oligodendrocytes [12]. Another relevant case is a protein of the Dps family (DNA-binding pro-
tein from starved cells) synthesized by Campylobacter jejuni [68]. This Dps protein from C.
jejuni (termed C-Dps) binds to sulfatide on the myelin and the nodes of Ranvier, eventually
causing rapid paranodal myelin detachment and down-modulation of sodium channels [68].
These events are thought to be involved in Guillain-Barré Syndrome (GBS) associated with C.
jejuni enteritis [68]. From the structural point of view, C-Dps protein was found to share 41
and 24% amino acid identity with Helicobacter pylori neutrophil-activating protein (HP-NAP)
and Escherichia coliDps, respectively [69]. GBS, also called polyneuropathy, is caused by demy-
elination of peripheral nerves, while multiple sclerosis (MS) is caused by demyelination of
nerves in the CNS. In any case, since sulfatase treatment does not eliminate proEtx binding
nor, apparently, Etx oligomerization in MDCK cultures, but significantly reduces the cytotoxic
effect of Etx on these cells, sulfatide binding is likely to be associated with steps leading to cell
death, presumably pore formation in raft domains. Sulfatase treatment of MDCK cells prior to
Etx incubation substantially decreases Etx induced cell death. However, no significant decrease
in oligomer formation was detected with the experimental approach used here. More work is
in progress to define the role of sulfate groups in the Etx cytotoxic pathway.
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Regarding MS, C. perfringens type B, an Etx-secreting strain and a non natural host in
humans, has recently been isolated from a young individual with first clinical presentation of
MS [70]. Since immunoreactivity to Etx in sera and CSF from people with MS is 10 times more
prevalent than that from healthy controls, and, moreover, Etx fits mechanistically with nascent
MS lesion formation (BBB permeability and oligodendrocyte cell death) the authors postulate
that Etx may be a candidate causative toxin for nascent MS lesions. In support of this, the
demyelination of organotipic cultures of cerebellar slices triggered by Etx was reported in a
recent study [12], without causing the death of oligodendrocytes. Thus, the mentioned work
also points to the putative role of Etx in the initial events of certain myelin pathologies. It is
noteworthy that this effect is exerted in a manner independent of pore formation and through
the activation of an undefined receptor-mediated pathway. Moreover, in a recent work [71] the
authors corroborated the Etx-induced demyelination, also in organotypic cerebellar cultures,
although Etx caused the selective death of oligodendrocytes in primary cell cultures, which was
dependent on MAL expression. Additionally, Etx intoxication results in some MS-like symp-
toms, such as visual dysfunction, incoordination and spastic paralysis [72]. In fact, the relation-
ship between some sheep-resident pathogens and MS was hypothesized some years ago, since
the prevalence of MS is high in global areas where sheep populations are concentrated [73].
The results presented herein add a molecular mechanism, the binding of Etx to sulfatide,
which would explain the cellular tropism of action of Etx inside the host and supports the pos-
tulated involvement of C. perfringens type B in the triggering of pathologies caused by
demyelination.
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